1Frothingham R.Quinolone safety and efficacy more important than potency[J].Emerg Infect Dis,2004,10(1):156-157.
2Owens RC.Fluoroquinolone-associated dysglycemias:a tale of two toxicities[J].Pharmacotherapy,2005,25(10):1291-1295.
3Mohr JF,McKinnon PS,Peymann PJ,et al.A retrospective,comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin,levofloxacin,ciprofloxacin,or ceftriaxone[J].Pharmacotherapy,2005,25:1303-139.
4Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care,1997,20:1183-1197.
5Greenberg AL,Decerbo M,Fan J.Gatifloxacin therapy associated with hypoglycemia[J].Clin Infect Dis,2005,40:1210-1211.
6Graumlich JF,Habis S,Avelino RR,et al.Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy:nested case-control study[J].Pharmacotherapy,2005,25:1296-1302.
7Friedrich LV,Dougherty R.Fatal hypoglycemia associated with levofloxacin[J].Pharmacotherapy,2004,24:1807-1812.
8Wang S,Rizvi AA.Levofloxacin-induced hypoglycemia in a nondiabetic patient[J].Am J Med Sci,2006,331:334-335.
9Frothingham R.Glucose homeostasis abnormalities associated with use of gatifloxacin[J].Clin Infect Dis,2005,41:1269-1276.
